Zacks Research Issues Positive Estimate for Plexus Earnings

Plexus Corp. (NASDAQ:PLXS) – Zacks Research lifted their Q2 2026 earnings per share (EPS) estimates for Plexus in a research note issued to investors on Wednesday, February 11th. Zacks Research analyst Team now forecasts that the technology company will post earnings of $1.62 per share for the quarter, up from their previous estimate of $1.51. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for Plexus’ current full-year earnings is $5.90 per share. Zacks Research also issued estimates for Plexus’ Q3 2026 earnings at $1.72 EPS, Q4 2026 earnings at $1.79 EPS, FY2026 earnings at $6.64 EPS, Q1 2027 earnings at $1.71 EPS, Q3 2027 earnings at $1.87 EPS, Q4 2027 earnings at $2.06 EPS, FY2027 earnings at $7.34 EPS, Q1 2028 earnings at $1.85 EPS and FY2028 earnings at $8.06 EPS.

Other analysts have also issued reports about the company. Wall Street Zen lowered Plexus from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Needham & Company LLC boosted their price objective on Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a report on Friday, January 30th. Benchmark upped their target price on Plexus from $165.00 to $195.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Williams Trading set a $195.00 price target on shares of Plexus in a research report on Wednesday, January 28th. Finally, Weiss Ratings upgraded shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $189.20.

Plexus Price Performance

Shares of NASDAQ PLXS opened at $195.95 on Monday. The firm has a market capitalization of $5.25 billion, a P/E ratio of 30.47 and a beta of 0.81. The firm’s 50-day moving average price is $173.44 and its 200-day moving average price is $152.18. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06. Plexus has a 1-year low of $103.43 and a 1-year high of $211.84.

Plexus (NASDAQ:PLXS) last released its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The company had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.07 billion. During the same quarter in the previous year, the business posted $1.73 EPS. Plexus’s revenue for the quarter was up 9.6% compared to the same quarter last year. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS.

Institutional Investors Weigh In On Plexus

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Salomon & Ludwin LLC bought a new position in shares of Plexus in the third quarter valued at approximately $30,000. Covestor Ltd boosted its position in Plexus by 207.7% in the fourth quarter. Covestor Ltd now owns 240 shares of the technology company’s stock worth $35,000 after purchasing an additional 162 shares during the last quarter. Allworth Financial LP grew its stake in Plexus by 70.1% in the 3rd quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock valued at $36,000 after purchasing an additional 103 shares during the period. Huntington National Bank increased its position in shares of Plexus by 41.5% during the 2nd quarter. Huntington National Bank now owns 324 shares of the technology company’s stock valued at $44,000 after purchasing an additional 95 shares during the last quarter. Finally, Johnson Financial Group Inc. bought a new stake in shares of Plexus during the 3rd quarter worth $72,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Insider Buying and Selling at Plexus

In other Plexus news, COO Oliver K. Mihm sold 2,327 shares of Plexus stock in a transaction on Tuesday, November 25th. The shares were sold at an average price of $143.18, for a total transaction of $333,179.86. Following the transaction, the chief operating officer directly owned 18,442 shares of the company’s stock, valued at $2,640,525.56. The trade was a 11.20% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Dean A. Foate sold 5,000 shares of the stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $204.89, for a total transaction of $1,024,450.00. Following the completion of the sale, the chairman owned 15,000 shares of the company’s stock, valued at approximately $3,073,350. This represents a 25.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 34,671 shares of company stock worth $6,832,649. 1.78% of the stock is currently owned by insiders.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.